ScinoPharm Taiwan Ltd (1789) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.019x

Based on the latest financial reports, ScinoPharm Taiwan Ltd (1789) has a cash flow conversion efficiency ratio of 0.019x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$199.47 Million ≈ $6.28 Million USD) by net assets (NT$10.31 Billion ≈ $324.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ScinoPharm Taiwan Ltd net asset quality index to measure how much of total assets are equity-financed.

ScinoPharm Taiwan Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how ScinoPharm Taiwan Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of ScinoPharm Taiwan Ltd to evaluate the quality of earnings relative to operating cash generation.

ScinoPharm Taiwan Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ScinoPharm Taiwan Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shanghai Titan Scientific Co. Ltd. A SHG:688133	0.029x
Bannerman Energy Ltd AU:BMN	-0.016x
Clientele JSE:CLI	-0.059x
Ulusoy Elektrik Imalat IS:ULUSE	0.793x
Radium Development Berhad KLSE:5313	-0.050x
Yulon Nissan Motor Co Ltd TW:2227	-0.012x
Xiamen Savings Environmental SHE:300056	-0.102x
Compania General de Electricidad SA SN:CGE	-0.004x

Annual Cash Flow Conversion Efficiency for ScinoPharm Taiwan Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of ScinoPharm Taiwan Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see ScinoPharm Taiwan Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$10.52 Billion ≈ $331.59 Million	NT$597.11 Million ≈ $18.81 Million	0.057x	-20.47%
2024-12-31	NT$10.53 Billion ≈ $331.62 Million	NT$750.91 Million ≈ $23.66 Million	0.071x	+219.91%
2023-12-31	NT$10.36 Billion ≈ $326.54 Million	NT$231.13 Million ≈ $7.28 Million	0.022x	-69.88%
2022-12-31	NT$10.45 Billion ≈ $329.23 Million	NT$773.79 Million ≈ $24.38 Million	0.074x	+52.66%
2021-12-31	NT$10.51 Billion ≈ $331.16 Million	NT$509.82 Million ≈ $16.06 Million	0.049x	-46.03%
2020-12-31	NT$10.53 Billion ≈ $331.73 Million	NT$946.31 Million ≈ $29.81 Million	0.090x	+16.88%
2019-12-31	NT$10.26 Billion ≈ $323.24 Million	NT$788.95 Million ≈ $24.86 Million	0.077x	-34.20%
2018-12-31	NT$10.54 Billion ≈ $332.04 Million	NT$1.23 Billion ≈ $38.80 Million	0.117x	+25.28%
2017-12-31	NT$10.42 Billion ≈ $328.20 Million	NT$971.71 Million ≈ $30.61 Million	0.093x	-42.70%
2016-12-31	NT$10.23 Billion ≈ $322.23 Million	NT$1.67 Billion ≈ $52.46 Million	0.163x	+53.63%
2015-12-31	NT$9.86 Billion ≈ $310.55 Million	NT$1.04 Billion ≈ $32.91 Million	0.106x	+11.90%
2014-12-31	NT$9.38 Billion ≈ $295.53 Million	NT$888.29 Million ≈ $27.99 Million	0.095x	-2.80%
2013-12-31	NT$9.64 Billion ≈ $303.82 Million	NT$939.47 Million ≈ $29.60 Million	0.097x	-9.97%
2012-12-31	NT$9.07 Billion ≈ $285.78 Million	NT$981.55 Million ≈ $30.92 Million	0.108x	-28.44%
2011-12-31	NT$8.56 Billion ≈ $269.67 Million	NT$1.29 Billion ≈ $40.78 Million	0.151x	-35.46%
2010-12-31	NT$6.68 Billion ≈ $210.37 Million	NT$1.56 Billion ≈ $49.29 Million	0.234x	-19.27%
2009-12-31	NT$4.47 Billion ≈ $140.89 Million	NT$1.30 Billion ≈ $40.89 Million	0.290x	-29.06%
2008-12-31	NT$3.44 Billion ≈ $108.39 Million	NT$1.41 Billion ≈ $44.34 Million	0.409x	+105.43%
2007-12-31	NT$2.53 Billion ≈ $79.82 Million	NT$504.50 Million ≈ $15.89 Million	0.199x	--

About ScinoPharm Taiwan Ltd

TW:1789 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$474.59 Million

NT$15.06 Billion TWD

Market Cap Rank

#12356 Global

#448 in Taiwan

Share Price

NT$19.05

Change (1 day)

-1.80%

52-Week Range

NT$16.65 - NT$28.25

All Time High

NT$55.57